Literature DB >> 30811803

Practice variation in the management of patent ductus arteriosus in extremely low birth weight infants in the United States: Survey results among cardiologists and neonatologists.

Shyam Sathanandam1, Stephanie Whiting1, Jorden Cunningham1, David Zurakowski2, Leah Apalodimas1, B Rush Waller1, Ranjit Philip1, Athar M Qureshi3.   

Abstract

BACKGROUND: Patent ductus arteriosus (PDA) is highly prevalent in extremely low birth weight (ELBW), preterm infants. There are diverse management approaches for the PDA in ELBW infants. The objectives of this research were to identify current PDA management practices among cardiologists and neonatologists in the United States, describe any significant differences in management, and describe areas where practices align.
METHODS: A survey of 10 questions based on the management of PDA in ELBW infants was conducted among 100 prominent neonatologists from 74 centers and 103 prominent cardiologists from 75 centers. Among the cardiologists, approximately 50% were interventionists who perform transcatheter PDA closures (TCPC). Fisher's exact test was performed to compare practice variations among neonatologists and cardiologists. A potentially biased audience including a combination of health care providers belonging to cardiology, neonatology, and surgery were also surveyed during the International PDA Symposium. The results of this survey were not included for statistical comparison, due to this audience being potentially influenced by the Symposium.
RESULTS: Statistically significant differences were identified between neonatologists and cardiologists regarding the impact of PDA closure on morbidity and mortality, with 80% cardiologists responding that it does vs 54% of neonatologists (P < 0.001), the need for PDA closure (P < .001), and the preferred method of PDA closure if indicated (P < .001). There was agreement between neonatologists and cardiologists on symptomatic therapy; however more neonatologists favored watchful waiting over intervention in contrast to more cardiologists favoring intervention over observation (77% vs 95%, P < .001). Survey responses also identified a need for further training and research on TCPC.
CONCLUSION: Neonatologists and cardiologists have notable differences in managing PDA, and continued discussion across cardiology and neonatology has the potential to facilitate more of a consensus on best management practices. Further investigation is needed to identify outcomes in transcatheter PDA closure, particularly in ELBW infants.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  ELBW; PDA; TCPC; practice variation; survey

Mesh:

Year:  2019        PMID: 30811803     DOI: 10.1111/chd.12729

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  9 in total

1.  A randomized trial of intravenous acetaminophen versus indomethacin for treatment of hemodynamically significant PDAs in VLBW infants.

Authors:  J M Davidson; J Ferguson; E Ivey; R Philip; M F Weems; A J Talati
Journal:  J Perinatol       Date:  2020-05-21       Impact factor: 2.521

Review 2.  Patent ductus arteriosus in preterm infants: is early transcatheter closure a paradigm shift?

Authors:  P Vali; S Lakshminrusimha; A Pelech; M Underwood; F Ing
Journal:  J Perinatol       Date:  2019-09-27       Impact factor: 3.225

3.  Enantiomer specific pharmacokinetics of ibuprofen in preterm neonates with patent ductus arteriosus.

Authors:  Aline G J Engbers; Robert B Flint; Swantje Völler; Johan C A de Klerk; Irwin K M Reiss; Peter Andriessen; Kian D Liem; Pieter L J Degraeuwe; Siska Croubels; Joske Millecam; Karel Allegaert; Sinno H P Simons; Catherijne A J Knibbe
Journal:  Br J Clin Pharmacol       Date:  2020-04-20       Impact factor: 4.335

4.  PATENT DUCTUS ARTERIOSUS CLOSURE: EXPERIENCE FROM A TERTIARY REFERRAL CENTER.

Authors:  Diogo Remi Oliveira Faim; Joaquim António Maia Tiago; Rui Jorge Simões Castelo; Andreia Sofia Santos Francisco; Rosa Ramalho Alves; António Manuel Guerra Santos Pires
Journal:  Rev Paul Pediatr       Date:  2020-11-27

5.  Echocardiographic Diagnosis and Hemodynamic Evaluation of Patent Ductus Arteriosus in Extremely Low Gestational Age Newborn (ELGAN) Infants.

Authors:  Yogen Singh; Alain Fraisse; Omer Erdeve; Begum Atasay
Journal:  Front Pediatr       Date:  2020-11-19       Impact factor: 3.418

Review 6.  Management of Patent Ductus Arteriosus in Premature Infants in 2020.

Authors:  Sarah Parkerson; Ranjit Philip; Ajay Talati; Shyam Sathanandam
Journal:  Front Pediatr       Date:  2021-02-11       Impact factor: 3.418

7.  Trend and Outcomes for Surgical Versus Transcatheter Patent Ductus Arteriosus Closure in Neonates and Infants at US Children's Hospitals.

Authors:  Michael T Kuntz; Steven J Staffa; Dionne Graham; David Faraoni; Philip Levy; James DiNardo; Nicola Maschietto; Viviane G Nasr
Journal:  J Am Heart Assoc       Date:  2021-12-31       Impact factor: 6.106

8.  Survey highlighting the lack of consensus on diagnosis and treatment of patent ductus arteriosus in prematurity.

Authors:  Tim Hundscheid; Afif El-Khuffash; Patrick J McNamara; Willem P de Boode
Journal:  Eur J Pediatr       Date:  2022-03-19       Impact factor: 3.860

Review 9.  Consensus Guidelines for the Prevention and Management of Periprocedural Complications of Transcatheter Patent Ductus Arteriosus Closure with the Amplatzer Piccolo Occluder in Extremely Low Birth Weight Infants.

Authors:  Shyam Sathanandam; Dan Gutfinger; Brian Morray; Darren Berman; Matthew Gillespie; Thomas Forbes; Jason N Johnson; Ruchira Garg; Sophie Malekzadeh-Milani; Alain Fraisse; Osman Baspinar; Evan M Zahn
Journal:  Pediatr Cardiol       Date:  2021-06-30       Impact factor: 1.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.